Search research articles
Contact Us
Filters
Showing results (201-210 of 248) with videos related to
Page
of 25
Sort By:
Therapeutic Advances in Medical Oncology
|
September 7, 2019
Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group
Changhoon Yoo, Hyeon-Su Im, Kyu-Pyo Kim, et al.
Clinical Epigenetics
|
July 10, 2015
Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX
Dae-Won Lee, Sae-Won Han, Yongjun Cha, et al.
The Oncologist
|
June 6, 2023
A Survey of Practice Patterns for Clinical Nodal Staging Prior to Neoadjuvant Chemotherapy in Breast Cancer
Han-Byoel Lee, Kyung-Hun Lee, Seok Hyun Song, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
April 5, 2019
A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer
Tae-Yong Kim, Hye Sook Han, Keun-Wook Lee, et al.
The New England Journal of Medicine
|
August 16, 2018
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
Jennifer K Litton, Hope S Rugo, Johannes Ettl, et al.
Cancer Research and Treatment
|
June 6, 2015
Effect of Time Interval between Breast-Conserving Surgery and Radiation Therapy on Outcomes of Node-Positive Breast Cancer Patients Treated with Adjuvant Doxorubicin/Cyclophosphamide Followed by Taxane
Hyeon Kang Koh, Kyung Hwan Shin, Kyubo Kim, et al.
Journal of Breast Cancer
|
November 20, 2023
Multidisciplinary Shared Decision Making for Fertility Preservation in Young Women With Breast Cancer
Soo Yeon Baek, Hong-Kyu Kim, Seho Park, et al.
Cancer Research and Treatment
|
February 21, 2018
Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)
In Hae Park, Seock-Ah Im, Kyung Hae Jung, et al.
JNCI Cancer Spectrum
|
April 28, 2020
Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy
Hope S Rugo, Johannes Ettl, Sara A Hurvitz, et al.
JHEP Reports : Innovation in Hepatology
|
June 9, 2025
Second-line pembrolizumab for advanced HCC: Meta-analysis of the phase III KEYNOTE-240 and KEYNOTE-394 studies
Richard S Finn, Kangsheng Gu, Xi Chen, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 248) with videos related to
Sort By:
Page
of 25
Therapeutic Advances in Medical Oncology
|
September 7, 2019
Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group
Changhoon Yoo, Hyeon-Su Im, Kyu-Pyo Kim, et al.
Clinical Epigenetics
|
July 10, 2015
Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX
Dae-Won Lee, Sae-Won Han, Yongjun Cha, et al.
The Oncologist
|
June 6, 2023
A Survey of Practice Patterns for Clinical Nodal Staging Prior to Neoadjuvant Chemotherapy in Breast Cancer
Han-Byoel Lee, Kyung-Hun Lee, Seok Hyun Song, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
April 5, 2019
A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer
Tae-Yong Kim, Hye Sook Han, Keun-Wook Lee, et al.
The New England Journal of Medicine
|
August 16, 2018
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
Jennifer K Litton, Hope S Rugo, Johannes Ettl, et al.
Cancer Research and Treatment
|
June 6, 2015
Effect of Time Interval between Breast-Conserving Surgery and Radiation Therapy on Outcomes of Node-Positive Breast Cancer Patients Treated with Adjuvant Doxorubicin/Cyclophosphamide Followed by Taxane
Hyeon Kang Koh, Kyung Hwan Shin, Kyubo Kim, et al.
Journal of Breast Cancer
|
November 20, 2023
Multidisciplinary Shared Decision Making for Fertility Preservation in Young Women With Breast Cancer
Soo Yeon Baek, Hong-Kyu Kim, Seho Park, et al.
Cancer Research and Treatment
|
February 21, 2018
Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)
In Hae Park, Seock-Ah Im, Kyung Hae Jung, et al.
JNCI Cancer Spectrum
|
April 28, 2020
Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy
Hope S Rugo, Johannes Ettl, Sara A Hurvitz, et al.
JHEP Reports : Innovation in Hepatology
|
June 9, 2025
Second-line pembrolizumab for advanced HCC: Meta-analysis of the phase III KEYNOTE-240 and KEYNOTE-394 studies
Richard S Finn, Kangsheng Gu, Xi Chen, et al.
Page
of 25